4893 items matching your search terms.

Perspectives of patients, nurses, and nephrologists about electronic symptom monitoring with feedback in hemodialysis care

Viecelli, A. K. Duncanson, E. Bennett, P. N. D'Antoine, M. Dansie, K. Handke, W. Tong, A. Palmer, S. Jesudason, S. McDonald, S. Morton, R. L. Symptom monitoring With Feedback Trial, Investigators
AMERICAN JOURNAL OF KIDNEY DISEASES, 2022     DOI:10.1053/j.ajkd.2021.12.007

Perspectives of Patients, Nurses, and Nephrologists About Electronic Symptom Monitoring With Feedback in Hemodialysis Care

Viecelli, A. K. Duncanson, E. Bennett, P. N. D'Antoine, M. Dansie, K. Handke, W. Tong, A. Palmer, S. Jesudason, S. McDonald, S. Morton, R. L. Symptom Monitoring With Feedback Trial, Investigators
AMERICAN JOURNAL OF KIDNEY DISEASES, 2022     DOI:10.1053/j.ajkd.2021.12.007

Premature death in kidney transplant recipients: The time for trials is now

Vinson, A. Singh, S. Chadban, S. Cherney, D. Gaber, O. Gill, J. Helgeson, E. Herzog, C. Jardine, M. Jha, V. Kasiske, B. Mannon, R. Michos, E. Mottl, A. Newby, K. Roy-Chaudhury, P. Sawinski, D. Sharif, A. Sridhar, V. Tuttle, K. Vock, D. Matas, A.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022     DOI:10.1681/ASN.2021111517

Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South-East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial

Wada, T. Mori-Anai, K. Kawaguchi, Y. Katsumata, H. Tsuda, H. Iida, M. Arakawa, K. Jardine, M. J.
J DIABETES INVESTIG, 2022     DOI:10.1111/jdi.13624

Circulating cystatin C is an independent risk marker for cardiovascular outcomes, development of renal impairment, and long-term mortality in patients with stable coronary heart disease: The LIPID study

West, M. Kirby, A. Stewart, R. A. Blankenberg, S. Sullivan, D. White, H. D. Hunt, D. Marschner, I. Janus, E. Kritharides, L. Watts, G. F. Simes, J. Tonkin, A. M. Lipid Study Group *
J AM HEART ASSOC, 2022     DOI:10.1161/JAHA.121.020745

Malignant melanocytic schwannian tumor and leptomeningeal disease: A case series with a focus on management

Woodford, R. Prather, L. Helfer, C. Davey, L. Penas-Prado, M. Armstrong, T. Tucker, K. Aldape, K. Gilbert, M. Clark, C. Thavaneswaran, S. Wang, D. Mandel, J. Kasherman, L.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022     DOI:10.1016/j.jns.2022.120291

PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer

Woodford, R. Zhou, D. Lord, S. J. Marschner, I. Cooper, W. A. Lewis, C. R. John, T. Yang, J. C. Lee, C. K.
FUTURE ONCOLOGY, 2022     DOI:10.2217/fon-2021-1184

The validity of progression-free survival 2 as a surrogate trial end point for overall survival

Woodford, R. G. Zhou, D. D. Kok, P. S. Lord, S. J. Friedlander, M. Marschner, I. C. Simes, R. J. Lee, C. K.
CANCER, 2022     DOI:10.1002/cncr.34085

Cannabinoids for symptom management in patients with kidney failure

Worth, H. O'Hara, D. Agarwal, N. Collister, D. Brennan, F. Smyth, B.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022     DOI:10.2215/CJN.11560821

Landscape of clinical trial activity focusing on Indigenous health in Australia: an overview using clinical trial registry data from 2008-2018

Xu, G. Modi, D. Hunter, K. E. Askie, L. M. Jamieson, L. M. Brown, A. Seidler, A. L.
BMC PUBLIC HEALTH, 2022     DOI:10.1186/s12889-022-13338-y

Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial

Abraham, M. B. de Bock, M. Smith, G. J. Dart, J. Fairchild, J. M. King, B. R. Ambler, G. R. Cameron, F. J. McAuley, S. A. Keech, A. C. Jenkins, A. Davis, E. A. O'Neal, D. N. Jones, T. W. Australian Juvenile Diabetes Research Fund Closed-Loop Research, group
JAMA PEDIATR, 2021     DOI:10.1001/jamapediatrics.2021.3965

Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial

Ackermann, D. M. Dieng, M. Medcalf, E. Jenkins, M. C. van Kemenade, C. H. Janda, M. Turner, R. M. Cust, A. E. Morton, R. L. Irwig, L. Guitera, P. Soyer, H. P. Mar, V. Hersch, J. K. Low, D. Low, C. Saw, R. P. M. Scolyer, R. A. Drabarek, D. Espinoza, D. Azzi, A. Lilleyman, A. M. Smit, A. K. Murchie, P. Thompson, J. F. Bell, K. J. L.
JAMA DERMATOL, 2021     DOI:10.1001/jamadermatol.2021.4704

Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial

Ackermann, D. M. Smit, A. K. Janda, M. van Kemenade, C. H. Dieng, M. Morton, R. L. Turner, R. M. Cust, A. E. Irwig, L. Hersch, J. K. Guitera, P. Soyer, H. P. Mar, V. Saw, R. P. M. Low, D. Low, C. Drabarek, D. Espinoza, D. Emery, J. Murchie, P. Thompson, J. F. Scolyer, R. A. Azzi, A. Lilleyman, A. Bell, K. J. L.
TRIALS, 2021     DOI:10.1186/s13063-021-05231-7

Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines

Agarwal, A. Livingstone, A. Karikios, D. J. Stockler, M. R. Beale, P. J. Morton, R. L.
BMC CANCER, 2021     DOI:10.1186/s12885-021-08697-5

Patient-reported outcome measures (PROMs) to guide clinical care: recommendations and challenges

Agarwal, A. Pain, T. Levesque, J. F. Girgis, A. Hoffman, A. Karnon, J. King, M. T. Shah, K. K. Morton, R. L. Hsraanz PROMs Special Interest Group
MEDICAL JOURNAL OF AUSTRALIA, 2021     DOI:10.5694/mja2.51355